LC
ZBH icon

Lawood & Co’s Zimmer Biomet ZBH Stock Holding History

Lawood & Co’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$322K Hold
3,740
– – 0.22% 75
2026
Q1 		$338K Sell
3,740
-50
-1% -$4.59K 0.31% 73
2025
Q4 		$341K Buy
+3,790
New +$359K 0.32% 70

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lawood & Co's ZBH Position: Q2 2026 in Review

Lawood & Co held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 3,740 shares worth $322K. The position accounts for 0.22% of the portfolio, ranked #75.

Lawood & Co first reported a position in ZBH in Q4 2025 and has held it in 3 quarters since. The position peaked at $341K in Q4 2025. 907 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Lawood & Co held 3,740 shares of Zimmer Biomet worth $322K as of Q2 2026.
  • Lawood & Co left its Zimmer Biomet share count unchanged in Q2 2026.
  • Zimmer Biomet made up 0.22% of Lawood & Co's portfolio in Q2 2026, its #75 holding.
  • Lawood & Co first reported a position in Zimmer Biomet in Q4 2025 and has held it in 3 quarters since.
  • Lawood & Co's Zimmer Biomet position peaked at $341K in Q4 2025.
  • 907 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Lawood & Co's 13F filing for Q2 2026, filed 13 Jul 2026.